Showing the latest 475 publications
Publications 401-410 of 475
-
eFORGE: A Tool for Identifying Cell Type-Specific Signal in Epigenomic Data
Breeze, C., Paul, D., van Dongen, J., Butcher, L., Ambrose, J., Barrett, J., et al.
Cell Reports
-
Distinct Trends of DNA Methylation Patterning in the Innate and Adaptive Immune Systems
Schuyler, R., Merkel, A., Raineri, E., Altucci, L., Vellenga, E., Martens, J., et al.
Cell Reports
-
Mutations in AGBL5, Encoding α-Tubulin Deglutamylase, Are Associated With Autosomal Recessive Retinitis Pigmentosa
Astuti, G., Arno, G., Hull, S., Pierrache, L., Venselaar, H., Carss, K., et al.
Investigative Ophthalmology & Visual Science
-
Phenotypic screening reveals TNFR2 as a promising target for cancer immunotherapy
Williams, G., Mistry, B., Guillard, S., Ulrichsen, J., Sandercock, A., Wang, J., et al.
Oncotarget
-
Regulatory T Cell Responses in Participants with Type 1 Diabetes after a Single Dose of Interleukin-2: A Non-Randomised, Open Label, Adaptive Dose-Finding Trial
Todd, J., Evangelou, M., Cutler, A., Pekalski, M., Walker, N., Stevens, H., et al.
PLoS medicine
-
Altered fibrinolysis in autosomal dominant thrombomodulin-associated coagulopathy
Burley, K., Whyte, C., Westbury, S., Walker, M., Stirrups, K., Turro, E., et al.
Blood
-
Opioid Antagonists and the A118G Polymorphism in the μ-Opioid Receptor Gene: Effects of GSK1521498 and Naltrexone in Healthy Drinkers Stratified by OPRM1 Genotype
Ziauddeen, H., Nestor, L., Subramaniam, N., Dodds, C., Nathan, P., Miller, S., et al.
Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology
-
Immunoseq: the identification of functionally relevant variants through targeted capture and sequencing of active regulatory regions in human immune cells
Morin, A., Kwan, T., Ge, B., Letourneau, L., Ban, M., Tandre, K., et al.
BMC medical genomics
-
Reevaluation of the Retinal Dystrophy Due to Recessive Alleles of RGR With the Discovery of a Cis-Acting Mutation in CDHR1
Arno, G., Hull, S., Carss, K., Dev-Borman, A., Chakarova, C., Bujakowska, K., et al.
Investigative Ophthalmology & Visual Science
-
The complement receptor 3 (CD11b/CD18) agonist Leukadherin-1 suppresses human innate inflammatory signalling
Roberts, A., Fürnrohr, B., Vyse, T., Rhodes, B.
Clinical and Experimental Immunology